A drug company that increased the price of a crucial thyroid remedy more than 10-fold has prompted fines of more than £100m by the competition watchdog. Advanz pushed up the price of thyroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback